Press releases

May 14, 2020
PathMaker Neurosystems Appoints Medtech Industry Veteran Hooman Hakami as Chairman of Company’s Board of Directors

July 25, 2019
PathMaker Neurosystems Announces Publication of First Clinical Trial Results for its MyoRegulator® Device for Non-Invasive Treatment of Spasticity

June 26, 2019
PathMaker Neurosystems is Named as Recipient of France’s Top Prize for Innovation

May 31, 2019
PathMaker Neurosystems Sponsored by NIH to Participate in the Innovation Zone at the 2019 BIO International Convention.

February 8, 2019
PathMaker Neurosystems Announces Publication of Scientific Paper Establishing First Linkage Between Spasticity and Overexpression of a Specific Neuronal Cotransporter

September 5, 2018
PathMaker Neurosystems Announces Initiation of Landmark European Clinical Trial Evaluating MyoRegulator™ for Non-Invasive Treatment of Spasticity

May 29, 2018
PathMaker Neurosystems Wins 2018 French-American Business Award for Startup of the Year

February 7, 2018
PathMaker Neurosystems Awarded Nearly $5 Million NIH Cooperative Agreement to Develop MyoRegulator™ for the Non-Invasive Treatment of Spasticity

January 31, 2018
PathMaker Neurosystems Announces the Addition of Professor Ole Isacson of Harvard Medical School to its Scientific Advisory Board

January 17, 2018
PathMaker Neurosystems Receives Award from Non-Profit Consortium to Support Development of MyoAmplifier™ for the Non-Invasive Treatment of Pediatric Paralysis and Muscle Weakness

February 15, 2017
Bpifrance awards PathMaker Neurosystems a PIA Grant to Support Product Development

January 23, 2017
PathMaker Neurosystems and France’s Brain and Spine Institute (ICM) Announce Establishment of Broad Relationship to Conduct European Clinical Trials for MyoRegulator

October 4, 2016
PathMaker Neurosystems Receives the Innovation Prize 2016

September 13, 2016
PathMaker Neurosystems Inc. Announces the Addition of Institute Professor Emilio Bizzi of MIT to its Scientific Advisory Board

July 26, 2016
PathMaker Neurosystems is Named as Finalist for the Innovation Prize 2016

June 25, 2016
PathMaker Neurosystems is Named as a Top 6 Neuroscience Startup at The Brain Forum conference

June 2, 2016
PathMaker Neurosystems Inc. Announces Key Patent Issuance by US Patent and Trademark Office for Fundamental Technology Covering MyoRegulator™

April 5, 2016
PathMaker Neurosystems and Feinstein Institute Announce Initiation of First Clinical Trial of MyoRegulator to Treat Muscle Contraction

January 11, 2016
PathMaker Neurosystems Inc. Announces the Addition of Deborah DiSanzo to the Company’s Board of Directors

October 29, 2015
PathMaker Neurosystems Inc. Receives Expedited Access Pathway Designation from FDA for MyoRegulator

September 15, 2015
PathMaker Neurosystems Inc. Announces Two Key Technology Patents Granted by US Patent and Trademark Office

July 13, 2015
PathMaker Neurosystems Inc. announces receipt of Milestone Achievement Program Award, $200,000, from Massachusetts Life Sciences Center

June 22, 2015
PathMaker Neurosystems Inc. announces establishment of European operations at the iPEPS-ICM bioincubator at the Brain and Spine Institute (ICM) in Paris, France

June 19, 2015
Pathmaker Neurosystems Inc. Named as Healthcare Semi-Finalist in Hello Tomorrow Challenge Global Start-Up Competition

June 10, 2015
Pathmaker Neurosystems Announces Engagement of HERNETICS for Industrial Design

May 20, 2015
PathMaker Neurosystems announces agreement with Proven Process Medical Devices for the development of non-invasive neuromodulation systems for treating neuromotor disorders

April 1, 2015
PathMaker Neurosystems Inc. announces selection as a Semi-Finalist for the 2015 BioVision Investor Conference

November 1, 2014
PathMaker Neurosystems Inc. announces selection as 2014 YEi Laureate in the Young Entrepreneurs Initiative competition put on by the French Consulate/Invest in France Agency